Filing Details

Accession Number:
0001088020-11-000023
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-03-03 16:56:06
Reporting Period:
2011-03-01
Filing Date:
2011-03-03
Accepted Time:
2011-03-03 16:56:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
911216 Palatin Technologies Inc PTN Pharmaceutical Preparations (2834) 954078884
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1103883 T Stephen Wills Palatin Technologies, Inc.
4C Cedar Brook Drive
Cranbury NJ 08512
Exec Vp - Operations & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-03-01 50,000 $0.00 98,024 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A common stock purchase warrant Acquisiton 2011-03-01 4,348 $0.00 4,348 $1.00
Common Stock Series B common stock purchase warrant Acquisiton 2011-03-01 45,652 $0.00 45,652 $1.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
4,348 2011-03-01 2016-03-01 No 4 P Direct
45,652 2012-03-02 2017-03-02 No 4 P Direct
Footnotes
  1. Included in the purchase of 50,000 Units at a price of $1.00 per Unit. Each Unit consisted of one share of common stock; a Series A Warrant exercisable immediately for 2/23 of a share of common stock at an exercise price of $1.00 per share, with an expiration date of March 1, 2016; and a Series B Warrant exercisable starting March 2, 2012 for 21/23 of a share of common stock at an exercise price of $1.00 per share, with an expiration date of March 2, 2017. Exercise of the Series B warrant is subject to stockholder approval of an increase in the issuer's authorized capital.